{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:17:48Z","timestamp":1771395468388,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to characterize the expression levels and identify the risk factors associated with Toll-like receptor 2 and 4 (TLR2\/4) mRNA in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus (T2DM) complicated with pulmonary infection, and to develop and internally validate a nomogram-based diagnostic model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 239 patients with T2DM admitted to our hospital between January and August 2025 were selected. Based on the presence of concurrent pulmonary infection at admission, they were divided into the T2DM group (n=128) and the T2DM with pulmonary infection group (n=111). TLR2\/4 mRNA expression levels, general characteristics, and peripheral blood inflammatory markers were compared between the two groups. Predictors were identified using LASSO regression and logistic regression to construct a discriminant model, with receiver operating characteristic (ROC) curves plotted. Internal validation employed 10-fold cross-validation and bootstrap-based optimism correction (B = 1000). Model performance was assessed via Hosmer-Lemeshow tests and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with T2DM and pulmonary infection exhibited significantly elevated levels of fasting blood glucose, inflammatory markers (WBC, NEUT, hsCRP, PCT, ESR), and TLR2\/4 mRNA expression, as well as higher rates of invasive procedures, compared with the T2DM group (all P &amp;lt; 0.05). Using LASSO feature selection followed by multivariable logistic regression, a diagnostic nomogram was developed incorporating TLR2, IL-6, TNF-\u03b1, ESR, age, and diabetes duration. The nomogram demonstrated excellent discrimination, with an apparent AUC of 0.987. Internal validation confirmed robust performance, yielding a 10-fold cross-validation AUC of 0.980 \u00b1 0.006 and a bootstrap optimism-corrected AUC of 0.980 (B = 1,000).The Hosmer\u2013Lemeshow test indicated good calibration (P &amp;gt; 0.05). DCA showed substantial net clinical benefit across threshold probabilities ranging from 0.10 to 0.60.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TLR2, IL-6, TNF-\u03b1, ESR, age, and duration of diabetes can serve as a combined biomarker panel to aid in the early diagnosis of pulmonary infection in T2DM patients at hospital admission. The proposed nomogram demonstrates strong diagnostic performance and potential clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1764904","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:11Z","timestamp":1771392791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and internal validation of a TLR2-based nomogram for diagnosing pulmonary infection in type 2 diabetes"],"prefix":"10.3389","volume":"17","author":[{"given":"Yingqian","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fufang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"Idf diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123408","article-title":"Characterizing the diabetes-induced pathological changes of the mouse lung by single-cell rna sequencing","volume":"363","author":"Tsai","year":"2025","journal-title":"Life Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/idr.S475917","article-title":"Association between covid-19 and diabetes management indices in Japanese type 2 diabetes mellitus patients: A single-center, retrospective study","volume":"17","author":"Furumachi","year":"2024","journal-title":"Infect Drug Resist"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni712","article-title":"Toll-like receptors control activation of adaptive immune responses","volume":"2","author":"Schnare","year":"2001","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/life13020550","article-title":"Impact of comorbidity of bronchial asthma and type 2 diabetes mellitus on the expression and functional activity of tlr2 and tlr4 receptors","volume":"13","author":"Radzyukevich","year":"2023","journal-title":"Life (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/jleuko\/qiae050","article-title":"Hyperglycemia amplifies tlr-mediated inflammatory response of M(Il4) macrophages to dyslipidemic ligands","volume":"116","author":"Badillo-Garcia","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3760\/cma.j.cn115791-20241203-00705","article-title":"Chinese guidelines for the prevention and treatment of diabetes (2024 edition)","volume":"17","author":"Chinese Diabetes Society","year":"2025","journal-title":"Chin J Diabetes Mellitus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2100275","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101044","article-title":"Diabetes, infection risk and covid-19","volume":"39","author":"Erener","year":"2020","journal-title":"Mol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059753","article-title":"Development and validation of a nomogram to predict the risk of peripheral artery disease in patients with type 2 diabetes mellitus","volume":"13","author":"Liang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01848-3","article-title":"An ifn\u03b3-dependent immune-endocrine circuit lowers blood glucose to potentiate the innate antiviral immune response","volume":"25","author":"\u0160estan","year":"2024","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.3390\/ijms25137105","article-title":"Pathology of diabetes-induced immune dysfunction","volume":"25","author":"Alexander","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.13350\/j.cjpb.220922","article-title":"Etiological characteristics of nosocomial infection in maintenance hemodialysis (Mhd) patients and the predictive value of sii, plr, and il-33 for infection","volume":"17","author":"Yang","year":"2022","journal-title":"Chin J Pathogen Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931871","article-title":"Bacteroides fragilis ameliorates cronobacter malonaticus lipopolysaccharide-induced pathological injury through modulation of the intestinal microbiota","volume":"13","author":"Ling","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/cells14191523","article-title":"Mitochondrial ros-er stress axis governs il-10 production in neutrophils and regulates inflammation in murine chlamydia pneumoniae lung infection","volume":"14","author":"Chou","year":"2025","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2025.06.021","article-title":"Il-6 trans-signalling is elevated in als models and drives tdp-43 induced inflammatory responses in microglia","volume":"129","author":"Risby-Jones","year":"2025","journal-title":"Brain Behav Immun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2108341","article-title":"Correlation of moraxella catarrhalis macrolide susceptibility with the ability to adhere and invade human respiratory epithelial cells","volume":"11","author":"Liu","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929213","article-title":"Host inflammatory response is the major factor in the progression of chlamydia psittaci pneumonia","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e28005","DOI":"10.2196\/28005","article-title":"Clinical, laboratory, and imaging features of covid-19 in a cohort of patients: cross-sectional comparative study","volume":"7","author":"Qaisieh","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by tlr4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3639\/i.issn.2095-3097.2024.10.006","article-title":"Differential diagnostic value of peripheral blood interleukin-6, toll-like receptor 2, and leukocyte differentiation antigen 14 expression for distinguishing pathogens in patients with severe pulmonary infection [in chinese","volume":"13","author":"Shi","year":"2024","journal-title":"Trans Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1764904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:13Z","timestamp":1771392793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1764904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":25,"alternative-id":["10.3389\/fendo.2026.1764904"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1764904","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1764904"}}